Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['kudos', 'cartitude 4', 'cartitude', 'cartitude 1']
kudos to all involved in cartitude 4 - fantastic results now out in nejm for cilta in len refractory mm and with updated cartitude 1 at asco showing mpfs 35 months !! cilta has raised the bar for what we can achieve with a one time therapy for patients 
BMT & Cellular therapy @Moffitt, Myeloma-Doc,researcher & true #myellenial, passionate about personalized approach to therapy, mum of 2littlewomen, tweetsmyown